New psoriasis pill shows promise in early trial
NCT ID NCT06723171
First seen Mar 13, 2026 · Last updated May 20, 2026 · Updated 7 times
Summary
This study tests whether a daily pill called IRX4204 can safely improve skin symptoms in adults with mild to moderate plaque psoriasis. About 20 participants will take the drug or a placebo for 28 days and have weekly checkups. The goal is to see if the drug clears or nearly clears psoriasis patches better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Not posted
Webster, Texas, 77598, United States
Conditions
Explore the condition pages connected to this study.